173 related articles for article (PubMed ID: 19186136)
1. Fold-unfold transitions in the selectivity and mechanism of action of the N-terminal fragment of the bactericidal/permeability-increasing protein (rBPI(21)).
Domingues MM; Lopes SC; Santos NC; Quintas A; Castanho MA
Biophys J; 2009 Feb; 96(3):987-96. PubMed ID: 19186136
[TBL] [Abstract][Full Text] [Related]
2. rBPI(21) promotes lipopolysaccharide aggregation and exerts its antimicrobial effects by (hemi)fusion of PG-containing membranes.
Domingues MM; Castanho MA; Santos NC
PLoS One; 2009 Dec; 4(12):e8385. PubMed ID: 20027298
[TBL] [Abstract][Full Text] [Related]
3. Use of native and recombinant bactericidal/permeability-increasing proteins (BPI) as antigens for detection of BPI-ANCA.
Schultz H; Csernok E; Johnston TW; Lockwood CM; Gross WL
J Immunol Methods; 1997 Jul; 205(2):127-33. PubMed ID: 9294593
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
Levy O; Sisson RB; Kenyon J; Eichenwald E; Macone AB; Goldmann D
Infect Immun; 2000 Sep; 68(9):5120-5. PubMed ID: 10948134
[TBL] [Abstract][Full Text] [Related]
5. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
Horwitz AH; Ammons WS; Bauer RJ; Dedrick R; Nadell R; Williams RE; Liu PS
J Endotoxin Res; 2004; 10(2):97-106. PubMed ID: 15120000
[TBL] [Abstract][Full Text] [Related]
6. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
[TBL] [Abstract][Full Text] [Related]
8. Inclusion of S-sepharose beads in the culture medium significantly improves recovery of secreted rBPI(21) from transfected CHO-K1 cells.
Horwitz AH; Carroll SF; Williams RE; Liu PS
Protein Expr Purif; 2000 Feb; 18(1):77-85. PubMed ID: 10648172
[TBL] [Abstract][Full Text] [Related]
9. The region around residue 115 of human bactericidal/permeability-increasing protein is not involved in lipopolysaccharide binding or bactericidal activity. Chemical synthesis and expression of a gene coding for the active domain and characterization of recombinant proteins.
Qi SY; Li Y; O'Connor CD
Biochem J; 1994 Mar; 298 Pt 3(Pt 3):711-8. PubMed ID: 8141787
[TBL] [Abstract][Full Text] [Related]
10. rBPI21 interacts with negative membranes endothermically promoting the formation of rigid multilamellar structures.
Domingues MM; Bianconi ML; Barbosa LR; Santiago PS; Tabak M; Castanho MA; Itri R; Santos NC
Biochim Biophys Acta; 2013 Nov; 1828(11):2419-27. PubMed ID: 23792068
[TBL] [Abstract][Full Text] [Related]
11. Dynamic turn conformation of a short tryptophan-rich cationic antimicrobial peptide and its interaction with phospholipid membranes.
Nichols M; Kuljanin M; Nategholeslam M; Hoang T; Vafaei S; Tomberli B; Gray CG; DeBruin L; Jelokhani-Niaraki M
J Phys Chem B; 2013 Nov; 117(47):14697-708. PubMed ID: 24195729
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin.
Elsbach P
Ciba Found Symp; 1994; 186():176-87; discussion 187-9. PubMed ID: 7768151
[TBL] [Abstract][Full Text] [Related]
13. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.
Ramamoorthy A; Thennarasu S; Tan A; Gottipati K; Sreekumar S; Heyl DL; An FY; Shelburne CE
Biochemistry; 2006 May; 45(20):6529-40. PubMed ID: 16700563
[TBL] [Abstract][Full Text] [Related]
14. Anti-neutrophil cytoplasmic autoantibodies (ANCA) to bactericidal/permeability-increasing (BPI) protein recognize the carboxyl terminal domain.
Dunn AC; Walmsley RS; Dedrick RL; Wakefield AJ; Lockwood CM
J Infect; 1999 Jul; 39(1):81-7. PubMed ID: 10468134
[TBL] [Abstract][Full Text] [Related]
15. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
[TBL] [Abstract][Full Text] [Related]
16. Interaction of two overlapped synthetic peptides from GB virus C with charged mono and bilayers.
Alay M; Haro I; Alsina MA; Girona V; Prat J; Busquets MA
Colloids Surf B Biointerfaces; 2013 May; 105():7-13. PubMed ID: 23352943
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial peptide rBPI21: a translational overview from bench to clinical studies.
Domingues MM; Santos NC; Castanho MA
Curr Protein Pept Sci; 2012 Nov; 13(7):611-9. PubMed ID: 23116442
[TBL] [Abstract][Full Text] [Related]
18. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains.
Lockwood NA; Haseman JR; Tirrell MV; Mayo KH
Biochem J; 2004 Feb; 378(Pt 1):93-103. PubMed ID: 14609430
[TBL] [Abstract][Full Text] [Related]
19. Log reduction of multidrug-resistant Gram-negative bacteria by the neutrophil-derived recombinant bactericidal/permeability-increasing protein.
Weitz A; Spotnitz R; Collins J; Ovadia S; Iovine NM
Int J Antimicrob Agents; 2013 Dec; 42(6):571-4. PubMed ID: 24189329
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury.
Arditi M; Zhou J; Huang SH; Luckett PM; Marra MN; Kim KS
Infect Immun; 1994 Sep; 62(9):3930-6. PubMed ID: 8063410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
